Journal article

Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk

Sara Lindstroem, Deborah J Thompson, Andrew D Paterson, Jingmei Li, Gretchen L Gierach, Christopher Scott, Jennifer Stone, Julie A Douglas, Isabel dos-Santos-Silva, Pablo Fernandez-Navarro, Jajini Verghase, Paula Smith, Judith Brown, Robert Luben, Nicholas J Wareham, Ruth JF Loos, John A Heit, V Shane Pankratz, Aaron Norman, Ellen L Goode Show all

Nature Communications | NATURE PUBLISHING GROUP | Published : 2014

Grants

Awarded by NIH


Awarded by Center for Inherited Disease Research (CIDR) - National Institutes of Health


Awarded by FIS from the Spain's Health Research Fund


Awarded by Astra-Zeneca


Awarded by Carlos III Institute of Health


Awarded by Cancer Research UK


Awarded by GAME-ON DRIVE


Awarded by European Community


Awarded by National Institutes of Health


Awarded by Post-Cancer GWAS initiative


Awarded by Department of Defence


Awarded by Medical Research Council


Awarded by National Institute for Health Research


Funding Acknowledgements

This study was supported by CA131332, CA087969, CA049449, CA128931, CA116201, CA075016, CA122340, CA122844, CA15083, CA089393, K22LM011931 and X01 HG005954 from NIH; genotyping services for the OOA study were provided by the Center for Inherited Disease Research (CIDR), which is fully funded through a federal contract from the National Institutes of Health to The Johns Hopkins University, contract number HHSN268200782096; The Breast Cancer Research Foundation, Breast Cancer Research Fund; Cancer Research UK; Marit & Hans Rausing's Initiative against Breast Cancer; Susan Komen Foundation; Agency for Science, Technology and Research of Singapore (A*STAR); David F. and Margaret T. Grohne Family Foundation; Campbell Family Institute for Breast Cancer Research; David F. and Margaret T. Grohne Family Foundation; Ontario Ministry of Health and Long Term Care; Fashion Footwear Charitable Foundation of New York/QVC Presents Shoes on Sale; FIS PI060386 from the Spain's Health Research Fund and EPY 1306/06 Collaboration Agreement between Astra-Zeneca and the Carlos III Institute of Health; Elizabeth C. Crosby Research Award, Gladys E. Davis Endowed Fund and the Office for Vice President of Research at the University of Michigan. EPIC-Norfolk was funded by research programme grant funding from Cancer Research UK and the Medical Research Council with additional support from the Stroke Association, British Heart Foundation, Department of Health, Research into Ageing and Academy of Medical Sciences. The SIBS study was supported by programme grant C1287/A10118 and project grants from Cancer Research UK (grant numbers C1287/8459). SEARCH is funded by a programme grant from Cancer Research UK (C490/A10124). The Polish Breast Cancer Study was supported (in part) by the Intramural Research Program of the National Institutes of Health, National Cancer Institute. The breast cancer meta-analysis is supported by the GAME-ON DRIVE (CA148065) and BCAC initiatives. We thank the BCAC, GAME-ON and DRIVE initiatives for generously sharing breast cancer association results for selected SNPs. We also thank the investigators in BCAC, PRACTICAL, CIMBA and OCAC for access to the iCOGS data for the replication analysis. BBCC was funded in part by the ELAN Programme of the Medical Faculty, Friedrich-Alexander University Erlangen-Nuremberg. We thank all the individuals who took part in these studies and all the researchers, clinicians, technicians and administrative staff who have enabled this work to be carried out. The OOA study investigators thank the members of the Amish community for their generous support and participation, the staff at the Amish Research Clinic for their dedicated recruitment and fieldwork efforts, the members of Dr Margarita Shultz's radiology clinic for their expert mammography services, the staff at the Center for Inherited Disease Research for their exceptional genotyping services, Drs Alan Shuldiner and Braxton Mitchell at the University of Maryland for their guidance and help with our fieldwork, and Terry Gliedt, Jennifer Greene Nidetz, Kristen Maas, Cris Van Hout, James MacDonald, Chris Plotts, Lubomir Hadjiiski and Chuan Zhou at the University of Michigan for their technical assistance with data management, entry and analysis and film digitization and scoring.The PBCS would like to thank Pei Chao and Michael Stagner from Information Management Services (Silver Spring, MD) for data management support; Laurie Burdette, Amy Hutchinson and Jeff Yuenger from the NCI Core Genotyping facility for genotyping support; the participants, physicians, pathologists, nurses and interviewers from participating centres in Poland for their efforts during fieldwork; Drs Jola Lissowska and Ewa Wesolowska from the Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland for their assistance with mammogram retrieval; Dr Norman Boyd from the University of Toronto for providing the mammographic density assessments; and Drs. Louise Brinton, Montserrat Garcia-Closas, Beata Peplonska and Mark Sherman for their contributions to the study design. We thank Paul Pharoah and the SEARCH and EPIC teams. The iCOGS project would not have been possible without the contributions of the following: Paul Pharoah, Kyriaki Michailidou, Manjeet K. Bolla, Qin Wang (BCAC), Andrew Berchuck (OCAC), Rosalind A. Eeles, Ali Amin Al Olama, Zsofia Kote-Jarai, Sara Benlloch (PRACTICAL), Georgia Chenevix-Trench, Antonis Antoniou, Lesley McGuffog and Ken Offit (CIMBA), Joe Dennis, Alison M. Dunning, Andrew Lee, and Ed Dicks, Craig Luccarini and the staff of the Centre for Genetic Epidemiology Laboratory, Javier Benitez, Anna Gonzalez-Neira and the staff of the CNIO genotyping unit, Jacques Simard and Daniel C. Tessier, Francois Bacot, Daniel Vincent, Sylvie LaBoissiere and Frederic Robidoux and the staff of the McGill University and Genome Quebec Innovation Centre, Stig E. Bojesen, Sune F. Nielsen, Borge G. Nordestgaard and the staff of the Copenhagen DNA laboratory, and Julie M. Cunningham, Sharon A. Windebank, Christopher A. Hilker, Jeffrey Meyer and the staff of Mayo Clinic Genotyping Core Facility. The iCOGS infrastructure was funded by the following: the European Community's Seventh Framework Programme under grant agreement no. 223175 (HEALTH-F2-2009-223175; COGS), Cancer Research UK (C1287/A10118, C1287/A 10710, C12292/A11174, C1281/A12014, C5047/A8384, C5047/A15007, C5047/A10692), the National Institutes of Health (CA128978) and Post-Cancer GWAS initiative (1U19 CA148537, 1U19 CA148065 and 1U19 CA148112-the GAME-ON initiative), the Department of Defence (W81XWH-10-1-0341), the Canadian Institutes of Health Research (CIHR) for the CIHR Team in Familial Risks of Breast Cancer, Komen Foundation for the Cure, the Breast Cancer Research Foundation and the Ovarian Cancer Research Fund. The results published here are in part based upon data generated by The Cancer Genome Atlas project established by the NCI and NHGRI (dbGaP Study Accession: phs000178.v8.p7). Information about TCGA and the investigators and institutions who constitute the TCGA research network can be found at http://cancergenome.nih.gov/.